ONO-7018, a First-in-Class MALT1 Inhibitor, Provides Novel Therapeutic Strategies for B Cell Malignancies: Overcoming BTK Inhibitor Acquired Resistance and Enhancing the Antitumor Effect of BTK Inhibitors

CTX-177 - Chordia Therap

Jaypirca (pirtobrutinib) - Eli Lilly

Velexbru (tirabrutinib) - Gilead

Ryu Fujikawa; Yuka Komichi; Kazuya Ono; Tomoko Yasuhiro; Sergio Prados; Takao Yoshida; Ryohei Kozaki

Dec 3, 2023